The influence of SLC19A1 gene polymorphisms on high dose methotrexate toxicity in childhood acute lymphoblastic leukemia and non-Hodgkin malignant lymphoma: introducing a haplotype based approach

Authors

  • Barbara Faganel Kotnik Department of oncology and haematology, University Children’s Hospital, University Medical Centre Ljubljana, Bohoričeva 20, Ljubljana, Slovenia
  • Janez Jazbec Department of oncology and haematology, University Children’s Hospital, University Medical Centre Ljubljana, Bohoričeva 20, Ljubljana, Slovenia
  • Petra Bohanec Grabar Pharmacogenetics Laboratory, Institute of Biochemistry Faculty of Medicine, University of Ljubljana Vrazov trg 2 SI-1000 Ljubljana Slovenia
  • Cristina Rodriguez-Antona Hereditary Endocrine Cancer Group Human Cancer Genetics Programme, Spanish National Cancer Center, Madrid, Spain
  • Vita Dolžan Pharmacogenetics Laboratory, Institute of Biochemistry Faculty of Medicine, University of Ljubljana Vrazov trg 2 SI-1000 Ljubljana Slovenia

Abstract

Background: We investigated the clinical relevance of SLC19A1 genetic variability for high dose methotrexate (HD-MTX) related toxicities in children and adolescents with acute lymphoblastic leukaemia (ALL) and non Hodgkin malignant lymphoma (NHML).

Mehods: Eighty-eight children and adolescents with ALL/NHML were investigated for the influence of SLC19A1 single nucleotide polymorphisms (SNPs) and haplotypes on HD-MTX induced toxicities.

Results: Patients with SLC19A1 rs2838958 TT genotype had higher probability for mucositis development as compared to carriers of at least one rs2838958 C allele (OR 0.226 (0.071-0.725), p<0.009). SLC19A1 TGTTCCG haplotype (H4) statistically significantly reduced the risk for the occurrence of adverse events during treatment with HD-MTX (OR 0.143 (0.023-0.852), p=0.030).

Discussion: SLC19A1 SNP and haplotype analysis could provide additional information for personalised HD-MTX therapy in children with ALL/NHML in order to achieve safer treatment. However further studies are needed to validate the results.

Downloads

Additional Files

Published

2017-11-27

How to Cite

Faganel Kotnik, B., Jazbec, J., Bohanec Grabar, P., Rodriguez-Antona, C., & Dolžan, V. (2017). The influence of SLC19A1 gene polymorphisms on high dose methotrexate toxicity in childhood acute lymphoblastic leukemia and non-Hodgkin malignant lymphoma: introducing a haplotype based approach. Radiology and Oncology, 51(4). Retrieved from https://www.radioloncol.com/index.php/ro/article/view/2778

Issue

Vol. 51 No. 4 (2017)

Section

Clinical oncology

License

License to Publish

Please read the terms of this agreement, print, initial page 1, sign page 3, scan and send the document as one file attached to an e-mail to gsersa@onko-i.si

Copyright - PDF